Nuclear assembly as a target for anti-cancer therapies

Nucleus (United States)

Volumn 5, Issue 1, 2014, Pages

  Gorjánácz, Mátyás ^a  

^a BAYER PHARMA AG   (Germany)

Author keywords

Anti mitotics; Barrier to autointegration factor; Cancer; Cell cycle; Drug discovery; Nuclear envelope; Nuclear organization; Nucleus; Vaccinia related kinase

Indexed keywords

ANTINEOPLASTIC AGENT; BARRIER TO AUTOINTEGRATION FACTOR; CYCLIN DEPENDENT KINASE 1; LAMIN; PHOSPHOPROTEIN PHOSPHATASE 1; PHOSPHOPROTEIN PHOSPHATASE 2A; POLO LIKE KINASE 1; PROTEIN KINASE C;

CANCER MORTALITY; CANCER THERAPY; CELL NUCLEUS MEMBRANE; CELL TRANSFORMATION; DOWN REGULATION; ENDOPLASMIC RETICULUM; GENE; GENE EXPRESSION; GENOMIC INSTABILITY; LMNA GENE; LMNB1 GENE; LMNB2 GENE; NUCLEAR PORE COMPLEX; NUCLEUS ORGANIZATION; PROTEIN EXPRESSION; REVIEW; TUMOR GROWTH;

EID: 84897505936     PISSN: 19491034     EISSN: 19491042     Source Type: Journal    
DOI: 10.4161/nucl.27928     Document Type: Review

References (123)

1. Chan KS, Koh CG, Li HY. Mitosis-targeted anti-cancer therapies: where they stand. Cell Death Dis 2012; 3:e411; PMID:23076219; http://dx.doi.org/10.1038/cddis.2012.148
2. Janssen A, Medema RH. Mitosis as an anti-cancer target. Oncogene 2011; 30:2799-809; PMID:21339734; http://dx.doi.org/10.1038/onc.2011.30
3. Jordan MA, Wilson L. Microtubules as a target for anticancer drugs. Nat Rev Cancer 2004; 4:253- 65; PMID:15057285; http://dx.doi.org/10.1038/ nrc1317
4. Gascoigne KE, Taylor SS. How do anti-mitotic drugs kill cancer cells? J Cell Sci 2009; 122:2579- 85; PMID:19625502; http://dx.doi.org/10.1242/jcs.039719
5. Huang HC, Mitchison TJ, Shi J. Stochastic competition between mechanistically independent slippage and death pathways determines cell fate during mitotic arrest. PLoS One 2010; 5:e15724; PMID:21203573; http://dx.doi.org/10.1371/journal.pone.0015724
6. Schmidt M, Bastians H. Mitotic drug targets and the development of novel anti-mitotic anticancer drugs. Drug Resist Updat 2007; 10:162-81; PMID:17669681; http://dx.doi.org/10.1016/j.drup.2007.06.003
7. Komlodi-Pasztor E, Sackett DL, Fojo AT. Inhibitors targeting mitosis: tales of how great drugs against a promising target were brought down by a flawed rationale. Clin Cancer Res 2012; 18:51-63; PMID:22215906; http://dx.doi.org/10.1158/1078-0432.CCR-11-0999
8. Mitchison TJ. The proliferation rate paradox in antimitotic chemotherapy. Mol Biol Cell 2012; 23:1- 6; PMID:22210845; http://dx.doi.org/10.1091/mbc.E10-04-0335
9. Komlodi-Pasztor E, Sackett D, Wilkerson J, Fojo T. Mitosis is not a key target of microtubule agents in patient tumors. Nat Rev Clin Oncol 2011; 8:244- 50; PMID:21283127; http://dx.doi.org/10.1038/nrclinonc.2010.228
10. Gorjánácz M, Jaedicke A, Mattaj IW. What can Caenorhabditis elegans tell us about the nuclear envelope? FEBS Lett 2007; 581:2794-801; PMID:17418822; http://dx.doi.org/10.1016/j.febslet.2007.03.052
11. Hetzer MW, Walther TC, Mattaj IW. Pushing the envelope: structure, function, and dynamics of the nuclear periphery. Annu Rev Cell Dev Biol 2005; 21:347-80; PMID:16212499; http://dx.doi.org/10.1146/annurev.cellbio.21.090704.151152
12. Dechat T, Pfleghaar K, Sengupta K, Shimi T, Shumaker DK, Solimando L, Goldman RD. Nuclear lamins: major factors in the structural organization and function of the nucleus and chromatin. Genes Dev 2008; 22:832-53; PMID:18381888; http://dx.doi.org/10.1101/gad.1652708
13. Dittmer TA, Misteli T. The lamin protein family. Genome Biol 2011; 12:222; PMID:21639948; http://dx.doi.org/10.1186/gb-2011-12-5-222
14. de Las Heras JI, Meinke P, Batrakou DG, Srsen V, Zuleger N, Kerr AR, Schirmer EC. Tissue specificity in the nuclear envelope supports its functional complexity. Nucleus 2013; 4:4; PMID:24213376; http://dx.doi.org/10.4161/nucl.26872
15. Lin F, Worman HJ. Expression of nuclear lamins in human tissues and cancer cell lines and transcription from the promoters of the lamin A/C and B1 genes. Exp Cell Res 1997; 236:378-84; PMID:9367621; http://dx.doi.org/10.1006/excr.1997.3735
16. Swift J, Ivanovska IL, Buxboim A, Harada T, Dingal PC, Pinter J, Pajerowski JD, Spinler KR, Shin JW, Tewari M, et al. Nuclear lamin-A scales with tissue stiffness and enhances matrix-directed differentiation. Science 2013; 341:1240104; PMID:23990565; http://dx.doi.org/10.1126/science.1240104
17. Ben-Harush K, Wiesel N, Frenkiel-Krispin D, Moeller D, Soreq E, Aebi U, Herrmann H, Gruenbaum Y, Medalia O. The supramolecular organization of the C. elegans nuclear lamin filament. J Mol Biol 2009; 386:1392-402; PMID:19109977; http://dx.doi.org/10.1016/j.jmb.2008.12.024
18. Goldberg MW, Huttenlauch I, Hutchison CJ, Stick R. Filaments made from A- and B-type lamins differ in structure and organization. J Cell Sci 2008; 121:215-25; PMID:18187453; http://dx.doi.org/10.1242/jcs.022020
19. Lammerding J, Fong LG, Ji JY, Reue K, Stewart CL, Young SG, Lee RT. Lamins A and C but not lamin B1 regulate nuclear mechanics. J Biol Chem 2006; 281:25768-80; PMID:16825190; http://dx.doi.org/10.1074/jbc.M513511200
20. Peric-Hupkes D, Meuleman W, Pagie L, Bruggeman SW, Solovei I, Brugman W, Gräf S, Flicek P, Kerkhoven RM, van Lohuizen M, et al. Molecular maps of the reorganization of genome-nuclear lamina interactions during differentiation. Mol Cell 2010; 38:603-13; PMID:20513434; http://dx.doi.org/10.1016/j.molcel.2010.03.016
21. Wiesel N, Mattout A, Melcer S, Melamed-Book N, Herrmann H, Medalia O, Aebi U, Gruenbaum Y. Laminopathic mutations interfere with the assembly, localization, and dynamics of nuclear lamins. Proc Natl Acad Sci U S A 2008; 105:180- 5; PMID:18162544; http://dx.doi.org/10.1073/pnas.0708974105
22. Melcer S, Gruenbaum Y, Krohne G. Invertebrate lamins. Exp Cell Res 2007; 313:2157-66; PMID:17451683; http://dx.doi.org/10.1016/j.yexcr.2007.03.004
23. Lammerding J, Hsiao J, Schulze PC, Kozlov S, Stewart CL, Lee RT. Abnormal nuclear shape and impaired mechanotransduction in emerin-deficient cells. J Cell Biol 2005; 170:781-91; PMID:16115958; http://dx.doi.org/10.1083/jcb.200502148
24. Chow KH, Factor RE, Ullman KS. The nuclear envelope environment and its cancer connections. Nat Rev Cancer 2012; 12:196-209; PMID:22337151
25. Las Heras JI, Batrakou DG, Schirmer EC. Cancer biology and the nuclear envelope: a convoluted relationship. Semin Cancer Biol 2013; 23:125-137; PMID:22311402; http://dx.doi.org/10.1016/j. semcancer.2012.01.008
26. Vargas JD, Hatch EM, Anderson DJ, Hetzer MW. Transient nuclear envelope rupturing during interphase in human cancer cells. Nucleus 2012; 3:88-100; PMID:22567193; http://dx.doi.org/10.4161/nucl.18954
27. Bussolati G. Proper detection of the nuclear shape: ways and significance. Rom J Morphol Embryol 2008; 49:435-9; PMID:19050790
28. Bussolati G, Marchiò C, Gaetano L, Lupo R, Sapino A. Pleomorphism of the nuclear envelope in breast cancer: a new approach to an old problem. J Cell Mol Med 2008; 12:209-18; PMID:18053086; http://dx.doi.org/10.1111/j.1582-4934.2007.00176.x
29. Fischer AH, Bardarov S Jr., Jiang Z. Molecular aspects of diagnostic nucleolar and nuclear envelope changes in prostate cancer. J Cell Biochem 2004; 91:170- 84; PMID:14689589; http://dx.doi.org/10.1002/ jcb.10735
30. Petersen I, Kotb WF, Friedrich KH, Schlüns K, Böcking A, Dietel M. Core classification of lung cancer: correlating nuclear size and mitoses with ploidy and clinicopathological parameters. Lung Cancer 2009; 65:312-8; PMID:19168259; http:// dx.doi.org/10.1016/j.lungcan.2008.12.013
31. Foster CR, Przyborski SA, Wilson RG, Hutchison CJ. Lamins as cancer biomarkers. Biochem Soc Trans 2010; 38:297-300; PMID:20074078; http://dx.doi.org/10.1042/BST0380297
32. Broers JL, Raymond Y, Rot MK, Kuijpers H, Wagenaar SS, Ramaekers FC. Nuclear A-type lamins are differentially expressed in human lung cancer subtypes. Am J Pathol 1993; 143:211-20; PMID:8391215
33. Kaufmann SH, Mabry M, Jasti R, Shaper JH. Differential expression of nuclear envelope lamins A and C in human lung cancer cell lines. Cancer Res 1991; 51:581-6; PMID:1985776
34. Machiels BM, Broers JL, Raymond Y, de Ley L, Kuijpers HJ, Caberg NE, Ramaekers FC. Abnormal A-type lamin organization in a human lung carcinoma cell line. Eur J Cell Biol 1995; 67:328-35; PMID:8521872
35. Belt EJ, Fijneman RJ, van den Berg EG, Bril H, Delis-van Diemen PM, Tijssen M, van Essen HF, de Lange-de Klerk E S, Beliën JA, Stockmann HB, et al. Loss of lamin A/C expression in stage II and III colon cancer is associated with disease recurrence. Eur J Cancer 2011; 47:1837-45; PMID:21621406; http://dx.doi.org/10.1016/j.ejca.2011.04.025
36. Moss SF, Krivosheyev V, de Souza A, Chin K, Gaetz HP, Chaudhary N, Worman HJ, Holt PR. Decreased and aberrant nuclear lamin expression in gastrointestinal tract neoplasms. Gut 1999; 45:723- 9; PMID:10517909; http://dx.doi.org/10.1136/gut.45.5.723
37. Wu Z, Wu L, Weng D, Xu D, Geng J, Zhao F. Reduced expression of lamin A/C correlates with poor histological differentiation and prognosis in primary gastric carcinoma. Journal of experimental & clinical cancer research. CR (East Lansing, Mich) 2009; 28:8
38. Capo-chichi CD, Cai KQ, Smedberg J, Ganjei-Azar P, Godwin AK, Xu XX. Loss of A-type lamin expression compromises nuclear envelope integrity in breast cancer. Chin J Cancer 2011; 30:415- 25; PMID:21627864; http://dx.doi.org/10.5732/cjc.010.10566
39. Wazir U, Ahmed MH, Bridger JM, Harvey A, Jiang WG, Sharma AK, Mokbel K. The clinicopathological significance of lamin A/C, lamin B1 and lamin B receptor mRNA expression in human breast cancer. Cell Mol Biol Lett 2013; 18:595-611; PMID:24293108; http://dx.doi.org/10.2478/ s11658-013-0109-9
40. Agrelo R, Setien F, Espada J, Artiga MJ, Rodriguez M, Pérez-Rosado A, Sanchez-Aguilera A, Fraga MF, Piris MA, Esteller M. Inactivation of the lamin A/C gene by CpG island promoter hypermethylation in hematologic malignancies, and its association with poor survival in nodal diffuse large B-cell lymphoma. J Clin Oncol 2005; 23:3940-7; PMID:15867203; http://dx.doi.org/10.1200/JCO.2005.11.650
41. Helfand BT, Wang Y, Pfleghaar K, Shimi T, Taimen P, Shumaker DK. Chromosomal regions associated with prostate cancer risk localize to lamin B-deficient microdomains and exhibit reduced gene transcription. J Pathol 2012; 226:735-45; PMID:22025297; http:// dx.doi.org/10.1002/path.3033
42. Funkhouser CM, Sknepnek R, Shimi T, Goldman AE, Goldman RD, Olvera de la Cruz M. Mechanical model of blebbing in nuclear lamin meshworks. Proc Natl Acad Sci U S A 2013; 110:3248-53; PMID:23401537; http://dx.doi.org/10.1073/pnas.1300215110
43. Capo-chichi CD, Cai KQ, Simpkins F, Ganjei-Azar P, Godwin AK, Xu XX. Nuclear envelope structural defects cause chromosomal numerical instability and aneuploidy in ovarian cancer. BMC Med 2011; 9:28; PMID:21439080; http://dx.doi.org/10.1186/1741-7015-9-28
44. Stadelmann B, Khandjian E, Hirt A, Lüthy A, Weil R, Wagner HP. Repression of nuclear lamin A and C gene expression in human acute lymphoblastic leukemia and non-Hodgkin's lymphoma cells. Leuk Res 1990; 14:815-21; PMID:2232854; http://dx.doi.org/10.1016/0145-2126(90)90076-L
45. Li L, Du Y, Kong X, Li Z, Jia Z, Cui J, Gao J, Wang G, Xie K. Lamin B1 is a novel therapeutic target of betulinic acid in pancreatic cancer. Clin Cancer Res 2013; 19:4651-61; PMID:23857605; http://dx.doi.org/10.1158/1078-0432.CCR-12-3630
46. Kong L, Schäfer G, Bu H, Zhang Y, Zhang Y, Klocker H. Lamin A/C protein is overexpressed in tissue-invading prostate cancer and promotes prostate cancer cell growth, migration and invasion through the PI3K/AKT/PTEN pathway. Carcinogenesis 2012; 33:751-9; PMID:22301279; http://dx.doi.org/10.1093/carcin/bgs022
47. nd, Yoshinaga Y, de Jong PJ, Vergnes L, Reue K, et al. Deficiencies in lamin B1 and lamin B2 cause neurodevelopmental defects and distinct nuclear shape abnormalities in neurons. Mol Biol Cell 2011; 22:4683-93; PMID:21976703; http://dx.doi.org/10.1091/mbc.E11-06-0504
48. Fukuda R, Hayashi A, Utsunomiya A, Nukada Y, Fukui R, Itoh K, Tezuka K, Ohashi K, Mizuno K, Sakamoto M, et al. Alteration of phosphatidylinositol 3-kinase cascade in the multilobulated nuclear formation of adult T cell leukemia/lymphoma (ATLL). Proc Natl Acad Sci U S A 2005; 102:15213- 8; PMID:16217039; http://dx.doi.org/10.1073/pnas.0507184102
49. Chuang CH, Carpenter AE, Fuchsova B, Johnson T, de Lanerolle P, Belmont AS. Long-range directional movement of an interphase chromosome site. Curr Biol 2006; 16:825-31; PMID:16631592; http:// dx.doi.org/10.1016/j.cub.2006.03.059
50. Weber SC, Spakowitz AJ, Theriot JA. Nonthermal ATP-dependent fluctuations contribute to the in vivo motion of chromosomal loci. Proc Natl Acad Sci U S A 2012; 109:7338-43; PMID:22517744; http:// dx.doi.org/10.1073/pnas.1119505109
51. Maraldi NM, Capanni C, Cenni V, Fini M, Lattanzi G. Laminopathies and lamin-associated signaling pathways. J Cell Biochem 2011; 112:979- 92; PMID:21400569; http://dx.doi.org/10.1002/ jcb.22992
52. De Vos WH, Houben F, Kamps M, Malhas A, Verheyen F, Cox J, Manders EM, Verstraeten VL, van Steensel MA, Marcelis CL, et al. Repetitive disruptions of the nuclear envelope invoke temporary loss of cellular compartmentalization in laminopathies. Hum Mol Genet 2011; 20:4175-86; PMID:21831885; http://dx.doi.org/10.1093/hmg/ ddr344
53. Capell BC, Collins FS. Human laminopathies: nuclei gone genetically awry. Nat Rev Genet 2006; 7:940-52; PMID:17139325; http://dx.doi.org/10.1038/ nrg1906
54. Willis ND, Cox TR, Rahman-Casañs SF, Smits K, Przyborski SA, van den Brandt P, van Engeland M, Weijenberg M, Wilson RG, de Bruïne A, et al. Lamin A/C is a risk biomarker in colorectal cancer. PLoS One 2008; 3:e2988; PMID:18714339; http://dx.doi.org/10.1371/journal.pone.0002988
55. Puckelwartz MJ, Depreux FF, McNally EM. Gene expression, chromosome position and lamin A/C mutations. Nucleus 2011; 2:162-7; PMID:21818408; http://dx.doi.org/10.4161/nucl.2.3.16003
56. Schirmer EC, Foisner R. Proteins that associate with lamins: many faces, many functions. Exp Cell Res 2007; 313:2167-79; PMID:17451680; http://dx.doi.org/10.1016/j.yexcr.2007.03.012
57. Wilson KL, Foisner R. Lamin-binding Proteins. Cold Spring Harb Perspect Biol 2010; 2:a000554; PMID:20452940; http://dx.doi.org/10.1101/ cshperspect.a000554
58. Bank EM, Ben-Harush K, Feinstein N, Medalia O, Gruenbaum Y. Structural and physiological phenotypes of disease-linked lamin mutations in C. elegans. J Struct Biol 2012; 177:106-12; PMID:22079399; http://dx.doi.org/10.1016/j. jsb.2011.10.009
59. Lammerding J, Lee RT. The nuclear membrane and mechanotransduction: impaired nuclear mechanics and mechanotransduction in lamin A/C deficient cells. Novartis Found Symp 2005; 264:264-73, discussion 273-8; PMID:15773759; http://dx.doi.org/10.1002/0470093765.ch18
60. Scaffidi P, Misteli T. Lamin A-dependent nuclear defects in human aging. Science 2006; 312:1059-63; PMID:16645051; http://dx.doi.org/10.1126/ science.1127168
61. Pekovic V, Harborth J, Broers JL, Ramaekers FC, van Engelen B, Lammens M, von Zglinicki T, Foisner R, Hutchison C, Markiewicz E. Nucleoplasmic LAP2alpha-lamin A complexes are required to maintain a proliferative state in human fibroblasts. J Cell Biol 2007; 176:163-72; PMID:17227891; http://dx.doi.org/10.1083/jcb.200606139
62. Meaburn KJ, Gudla PR, Khan S, Lockett SJ, Misteli T. Disease-specific gene repositioning in breast cancer. J Cell Biol 2009; 187:801-12; PMID:19995938; http://dx.doi.org/10.1083/jcb.200909127
63. Fischer AH, Taysavang P, Jhiang SM. Nuclear envelope irregularity is induced by RET/PTC during interphase. Am J Pathol 2003; 163:1091-1100; PMID:12937150; http://dx.doi.org/10.1016/ S0002-9440(10)63468-2
64. Gorjánácz M. LEM-4 promotes rapid dephosphorylation of BAF during mitotic exit. Nucleus 2013; 4:14-7; PMID:23211644; http:// dx.doi.org/10.4161/nucl.22961
65. Bollen M, Gerlich DW, Lesage B. Mitotic phosphatases: from entry guards to exit guides. Trends Cell Biol 2009; 19:531-41; PMID:19734049; http://dx.doi.org/10.1016/j.tcb.2009.06.005
66. Wurzenberger C, Gerlich DW. Phosphatases: providing safe passage through mitotic exit. Nat Rev Mol Cell Biol 2011; 12:469-82; PMID:21750572; http://dx.doi.org/10.1038/nrm3149
67. Gong D, Pomerening JR, Myers JW, Gustavsson C, Jones JT, Hahn AT, Meyer T, Ferrell JE Jr. Cyclin A2 regulates nuclear-envelope breakdown and the nuclear accumulation of cyclin B1. Curr Biol 2007; 17:85-91; PMID:17208191; http://dx.doi.org/10.1016/j.cub.2006.11.066
68. Laurell E, Beck K, Krupina K, Theerthagiri G, Bodenmiller B, Horvath P, Aebersold R, Antonin W, Kutay U. Phosphorylation of Nup98 by multiple kinases is crucial for NPC disassembly during mitotic entry. Cell 2011; 144:539-50; PMID:21335236; http://dx.doi.org/10.1016/j.cell.2011.01.012
69. Peter M, Nakagawa J, Dorée M, Labbé JC, Nigg EA. In vitro disassembly of the nuclear lamina and M phase-specific phosphorylation of lamins by cdc2 kinase. Cell 1990; 61:591-602; PMID:2188731; http://dx.doi.org/10.1016/0092-8674(90)90471-P
70. Gorjánácz M, Mattaj IW. Lipin is required for efficient breakdown of the nuclear envelope in Caenorhabditis elegans. J Cell Sci 2009; 122:1963- 9; PMID:19494125; http://dx.doi.org/10.1242/ jcs.044750
71. Mall M, Walter T, Gorjánácz M, Davidson IF, Nga Ly-Hartig TB, Ellenberg J, Mattaj IW. Mitotic lamin disassembly is triggered by lipid-mediated signaling. J Cell Biol 2012; 198:981-90; PMID:22986494; http://dx.doi.org/10.1083/jcb.201205103
72. Portier N, Audhya A, Maddox PS, Green R A, Dammermann A, Desai A, Oegema K. A microtubule-independent role for centrosomes and aurora a in nuclear envelope breakdown. Dev Cell 2007; 12:515-29; PMID:17419991; http://dx.doi.org/10.1016/j.devcel.2007.01.019
73. Li H, Liu XS, Yang X, Song B, Wang Y, Liu X. Polo-like kinase 1 phosphorylation of p150Glued facilitates nuclear envelope breakdown during prophase. Proc Natl Acad Sci U S A 2010; 107:14633- 8; PMID:20679239; http://dx.doi.org/10.1073/pnas.1006615107
74. Asencio C, Davidson IF, Santarella-Mellwig R, Ly-Hartig TB, Mall M, Wallenfang MR, Mattaj IW, Gorjánácz M. Coordination of kinase and phosphatase activities by Lem4 enables nuclear envelope reassembly during mitosis. Cell 2012; 150:122-35; PMID:22770216; http://dx.doi.org/10.1016/j.cell.2012.04.043
75. Gorjánácz M, Klerkx EP, Galy V, Santarella R, López-Iglesias C, Askjaer P, Mattaj IW. Caenorhabditis elegans BAF-1 and its kinase VRK-1 participate directly in post-mitotic nuclear envelope assembly. EMBO J 2007; 26:132-43; PMID:17170708; http:// dx.doi.org/10.1038/sj.emboj.7601470
76. Nichols RJ, Wiebe MS, Traktman P. The vaccinia-related kinases phosphorylate the N' terminus of BAF, regulating its interaction with DNA and its retention in the nucleus. Mol Biol Cell 2006; 17:2451-64; PMID:16495336; http://dx.doi.org/10.1091/mbc. E05-12-1179
77. Kim W, Chakraborty G, Kim S, Shin J, Park CH, Jeong MW, Bharatham N, Yoon HS, Kim KT. Macro histone H2A1.2 (macroH2A1) protein suppresses mitotic kinase VRK1 during interphase. J Biol Chem 2012; 287:5278-89; PMID:22194607; http://dx.doi.org/10.1074/jbc.M111.281709
78. Lu L, Ladinsky MS, Kirchhausen T. Cisternal organization of the endoplasmic reticulum during mitosis. Mol Biol Cell 2009; 20:3471-80; PMID:19494040; http://dx.doi.org/10.1091/mbc. E09-04-0327
79. Vagnarelli P, Ribeiro S, Sennels L, Sanchez-Pulido L, de Lima Alves F, Verheyen T, Kelly DA, Ponting CP, Rappsilber J, Earnshaw WC. Repo-Man coordinates chromosomal reorganization with nuclear envelope reassembly during mitotic exit. Dev Cell 2011; 21:328-42; PMID:21820363; http://dx.doi.org/10.1016/j.devcel.2011.06.020
80. Ramadan K, Bruderer R, Spiga FM, Popp O, Baur T, Gotta M, Meyer HH. Cdc48/p97 promotes reformation of the nucleus by extracting the kinase Aurora B from chromatin. Nature 2007; 450:1258- 62; PMID:18097415; http://dx.doi.org/10.1038/ nature06388
81. Anderson DJ, Hetzer MW. Nuclear envelope formation by chromatin-mediated reorganization of the endoplasmic reticulum. Nat Cell Biol 2007; 9:1160-6; PMID:17828249; http://dx.doi.org/10.1038/ncb1636
82. Anderson DJ, Hetzer MW. Reshaping of the endoplasmic reticulum limits the rate for nuclear envelope formation. J Cell Biol 2008; 182:911- 24; PMID:18779370; http://dx.doi.org/10.1083/ jcb.200805140
83. Lu L, Ladinsky MS, Kirchhausen T. Formation of the postmitotic nuclear envelope from extended ER cisternae precedes nuclear pore assembly. J Cell Biol 2011; 194:425-40; PMID:21825076; http://dx.doi.org/10.1083/jcb.201012063
84. Ulbert S, Platani M, Boue S, Mattaj IW. Direct membrane protein-DNA interactions required early in nuclear envelope assembly. J Cell Biol 2006; 173:469-76; PMID:16717124; http://dx.doi.org/10.1083/jcb.200512078
85. Anderson DJ, Vargas JD, Hsiao JP, Hetzer MW. Recruitment of functionally distinct membrane proteins to chromatin mediates nuclear envelope formation in vivo. J Cell Biol 2009; 186:183-91; PMID:19620630; http://dx.doi.org/10.1083/ jcb.200901106
86. Liu J, Lee KK, Segura-Totten M, Neufeld E, Wilson KL, Gruenbaum Y. MAN1 and emerin have overlapping function(s) essential for chromosome segregation and cell division in Caenorhabditis elegans. Proc Natl Acad Sci U S A 2003; 100:4598- 603; PMID:12684533; http://dx.doi.org/10.1073/pnas.0730821100
87. Kaláb P, Pralle A, Isacoff EY, Heald R, Weis K. Analysis of a RanGTP-regulated gradient in mitotic somatic cells. Nature 2006; 440:697- 701; PMID:16572176; http://dx.doi.org/10.1038/ nature04589
88. Lu X, Shi Y, Lu Q, Ma Y, Luo J, Wang Q, Ji J, Jiang Q, Zhang C. Requirement for lamin B receptor and its regulation by importin beta and phosphorylation in nuclear envelope assembly during mitotic exit. J Biol Chem 2010; 285:33281-93; PMID:20576617; http:// dx.doi.org/10.1074/jbc.M110.102368
89. Ma Y, Cai S, Lv Q, Jiang Q, Zhang Q, Sodmergen, Zhai Z, Zhang C. Lamin B receptor plays a role in stimulating nuclear envelope production and targeting membrane vesicles to chromatin during nuclear envelope assembly through direct interaction with importin beta. J Cell Sci 2007; 120:520- 30; PMID:17251381; http://dx.doi.org/10.1242/ jcs.03355
90. Polioudaki H, Kourmouli N, Drosou V, Bakou A, Theodoropoulos PA, Singh PB, Giannakouros T, Georgatos SD. Histones H3/H4 form a tight complex with the inner nuclear membrane protein LBR and heterochromatin protein 1. EMBO Rep 2001; 2:920- 5; PMID:11571267; http://dx.doi.org/10.1093/ embo-reports/kve199
91. Ye Q, Worman HJ. Interaction between an integral protein of the nuclear envelope inner membrane and human chromodomain proteins homologous to Drosophila HP1. J Biol Chem 1996; 271:14653- 6; PMID:8663349; http://dx.doi.org/10.1074/ jbc.271.25.14653
92. Audhya A, Desai A, Oegema K. A role for Rab5 in structuring the endoplasmic reticulum. J Cell Biol 2007; 178:43-56; PMID:17591921; http://dx.doi.org/10.1083/jcb.200701139
93. Golden A, Liu J, Cohen-Fix O. Inactivation of the C. elegans lipin homolog leads to ER disorganization and to defects in the breakdown and reassembly of the nuclear envelope. J Cell Sci 2009; 122:1970- 8; PMID:19494126; http://dx.doi.org/10.1242/ jcs.044743
94. Bradley CM, Ronning DR, Ghirlando R, Craigie R, Dyda F. Structural basis for DNA bridging by barrier-to-autointegration factor. Nat Struct Mol Biol 2005; 12:935-6; PMID:16155580; http://dx.doi.org/10.1038/nsmb989
95. Cai M, Huang Y, Suh JY, Louis JM, Ghirlando R, Craigie R, Clore GM. Solution NMR structure of the barrier-to-autointegration factor-Emerin complex. J Biol Chem 2007; 282:14525-35; PMID:17355960; http://dx.doi.org/10.1074/jbc.M700576200
96. Puente XS, Quesada V, Osorio FG, Cabanillas R, Cadiñanos J, Fraile JM, Ordóñez GR, Puente DA, Gutiérrez-Fernández A, Fanjul-Fernández M, et al. Exome sequencing and functional analysis identifies BANF1 mutation as the cause of a hereditary progeroid syndrome. Am J Hum Genet 2011; 88:650- 6; PMID:21549337; http://dx.doi.org/10.1016/j. ajhg.2011.04.010
97. Schmitz MH, Held M, Janssens V, Hutchins JR, Hudecz O, Ivanova E, Goris J, Trinkle-Mulcahy L, Lamond AI, Poser I, et al. Live-cell imaging RNAi screen identifies PP2A-B55alpha and importin-beta1 as key mitotic exit regulators in human cells. Nat Cell Biol 2010; 12:886-93; PMID:20711181; http:// dx.doi.org/10.1038/ncb2092
98. Chen GI, Tisayakorn S, Jorgensen C, D'Ambrosio LM, Goudreault M, Gingras AC. PP4R4/KIAA1622 forms a novel stable cytosolic complex with phosphoprotein phosphatase 4. J Biol Chem 2008; 283:29273-84; PMID:18715871; http://dx.doi.org/10.1074/jbc.M803443200
99. Glatter T, Wepf A, Aebersold R, Gstaiger M. An integrated workflow for charting the human interaction proteome: insights into the PP2A system. Mol Syst Biol 2009; 5:237; PMID:19156129; http:// dx.doi.org/10.1038/msb.2008.75
100. Zhuang X, Semenova E, Maric D, Craigie R. Dephosphorylation of Barrier-to-autointegration Factor by Protein Phosphatase 4 and Its Role in Cell Mitosis. J Biol Chem 2014; 289:1119-27; PMID:24265311; http://dx.doi.org/10.1074/jbc. M113.492777
101. Haraguchi T, Kojidani T, Koujin T, Shimi T, Osakada H, Mori C, Yamamoto A, Hiraoka Y. Live cell imaging and electron microscopy reveal dynamic processes of BAF-directed nuclear envelope assembly. J Cell Sci 2008; 121:2540-54; PMID:18628300; http://dx.doi.org/10.1242/jcs.033597
102. Doucet CM, Talamas JA, Hetzer MW. Cell cycle- dependent differences in nuclear pore complex assembly in metazoa. Cell 2010; 141:1030-41; PMID:20550937; http://dx.doi.org/10.1016/j. cell.2010.04.036
103. Baur T, Ramadan K, Schlundt A, Kartenbeck J, Meyer HH. NSF- and SNARE-mediated membrane fusion is required for nuclear envelope formation and completion of nuclear pore complex assembly in Xenopus laevis egg extracts. J Cell Sci 2007; 120:2895-903; PMID:17666429; http://dx.doi.org/10.1242/jcs.010181
104. Loewinger L, McKeon F. Mutations in the nuclear lamin proteins resulting in their aberrant assembly in the cytoplasm. EMBO J 1988; 7:2301-9; PMID:3056713
105. Galy V, Mattaj IW, Askjaer P. Caenorhabditis elegans nucleoporins Nup93 and Nup205 determine the limit of nuclear pore complex size exclusion in vivo. Mol Biol Cell 2003; 14:5104-15; PMID:12937276; http://dx.doi.org/10.1091/mbc.E03-04-0237
106. Yang SH, Jung HJ, Coffinier C, Fong LG, Young SG. Are B-type lamins essential in all mammalian cells? Nucleus 2011; 2:562-9; PMID:22127257; http:// dx.doi.org/10.4161/nucl.2.6.18085
107. Yang SH, Chang SY, Yin L, Tu Y, Hu Y, Yoshinaga Y, de Jong PJ, Fong LG, Young SG. An absence of both lamin B1 and lamin B2 in keratinocytes has no effect on cell proliferation or the development of skin and hair. Hum Mol Genet 2011; 20:3537-44; PMID:21659336; http://dx.doi.org/10.1093/hmg/ ddr266
108. Hruz T, Laule O, Szabo G, Wessendorp F, Bleuler S, Oertle L, Widmayer P, Gruissem W, Zimmermann P. Genevestigator v3: a reference expression database for the meta-analysis of transcriptomes. Adv Bioinformatics 2008; 2008:420747; PMID:19956698; http://dx.doi.org/10.1155/2008/420747
109. Uhlen M, Oksvold P, Fagerberg L, Lundberg E, Jonasson K, Forsberg M, Zwahlen M, Kampf C, Wester K, Hober S, et al. Towards a knowledge- based Human Protein Atlas. Nat Biotechnol 2010; 28:1248-50; PMID:21139605; http://dx.doi.org/10.1038/nbt1210-1248
110. Molitor TP, Traktman P. Molecular genetic analysis of VRK1 in mammary epithelial cells: depletion slows proliferation in vitro and tumor growth and metastasis in vivo. Oncogenesis 2013; 2:e48; PMID:23732708; http://dx.doi.org/10.1038/oncsis.2013.11
111. Kim W, Lyu HN, Kwon HS, Kim YS, Lee KH, Kim DY, Chakraborty G, Choi KY, Yoon HS, Kim KT. Obtusilactone B from Machilus Thunbergii targets barrier-to-autointegration factor to treat cancer. Mol Pharmacol 2013; 83:367-76; PMID:23150487; http://dx.doi.org/10.1124/mol.112.082578
112. Steen RL, Collas P. Mistargeting of B-type lamins at the end of mitosis: implications on cell survival and regulation of lamins A/C expression. J Cell Biol 2001; 153:621-6; PMID:11331311; http://dx.doi.org/10.1083/jcb.153.3.621
113. Steen RL, Martins SB, Taskén K, Collas P. Recruitment of protein phosphatase 1 to the nuclear envelope by A-kinase anchoring protein AKAP149 is a prerequisite for nuclear lamina assembly. J Cell Biol 2000; 150:1251-62; PMID:10995432; http://dx.doi.org/10.1083/jcb.150.6.1251
114. Rolland D, Camara-Clayette V, Barbarat A, Salles G, Coiffier B, Ribrag V, Thieblemont C. Farnesyltransferase inhibitor R115777 inhibits cell growth and induces apoptosis in mantle cell lymphoma. Cancer Chemother Pharmacol 2008; 61:855-63; PMID:17639395; http://dx.doi.org/10.1007/s00280-007-0543-3
115. Wärnberg F, White D, Anderson E, Knox F, Clarke RB, Morris J, Bundred NJ. Effect of a farnesyl transferase inhibitor (R115777) on ductal carcinoma in situ of the breast in a human xenograft model and on breast and ovarian cancer cell growth in vitro and in vivo. Breast Cancer Res 2006; 8:R21; PMID:16611371; http://dx.doi.org/10.1186/bcr1395
116. Magnaghi P, D'Alessio R, Valsasina B, Avanzi N, Rizzi S, Asa D, Gasparri F, Cozzi L, Cucchi U, Orrenius C, et al. Covalent and allosteric inhibitors of the ATPase VCP/p97 induce cancer cell death. Nat Chem Biol 2013; 9:548-56; PMID:23892893; http://dx.doi.org/10.1038/nchembio.1313
117. Chen W, Wang Z, Jiang C, Ding Y. PP2A-Mediated Anticancer Therapy. Gastroenterol Res Pract 2013; 2013:675429; PMID:24307892; http://dx.doi.org/10.1155/2013/675429
118. Kalev P, Sablina AA. Protein phosphatase 2A as a potential target for anticancer therapy. Anticancer Agents Med Chem 2011; 11:38-46; PMID:21288198; http://dx.doi.org/10.2174/187152011794941172
119. Beaudouin J, Gerlich D, Daigle N, Eils R, Ellenberg J. Nuclear envelope breakdown proceeds by microtubule-induced tearing of the lamina. Cell 2002; 108:83-96; PMID:11792323; http://dx.doi.org/10.1016/S0092-8674(01)00627-4
120. Mühlhäusser P, Kutay U. An in vitro nuclear disassembly system reveals a role for the RanGTPase system and microtubule-dependent steps in nuclear envelope breakdown. J Cell Biol 2007; 178:595- 610; PMID:17698605; http://dx.doi.org/10.1083/ jcb.200703002
121. Brinkmann V, Reichard U, Goosmann C, Fauler B, Uhlemann Y, Weiss DS, Weinrauch Y, Zychlinsky A. Neutrophil extracellular traps kill bacteria. Science 2004; 303:1532-5; PMID:15001782; http://dx.doi.org/10.1126/science.1092385
122. Olins AL, Zwerger M, Herrmann H, Zentgraf H, Simon AJ, Monestier M, Olins DE. The human granulocyte nucleus: Unusual nuclear envelope and heterochromatin composition. Eur J Cell Biol 2008; 87:279-90; PMID:18396345; http://dx.doi.org/10.1016/j.ejcb.2008.02.007
123. Hoffmann K, Sperling K, Olins AL, Olins DE. The granulocyte nucleus and lamin B receptor: avoiding the ovoid. Chromosoma 2007; 116:227- 35; PMID:17245605; http://dx.doi.org/10.1007/ s00412-007-0094-8